Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Long-term study of molindone hydrochloride in chronic schizophrenics.

Kellner R, Rada RT, Egelman A, Macaluso B.

Curr Ther Res Clin Exp. 1976 Nov;20(5):686-94. No abstract available.

PMID:
825355
2.

Long-term use of molindone in schizophrenics.

Abuzzahab FS.

J Clin Pharmacol. 1973 Oct;13(10):422-6. No abstract available.

PMID:
4583573
3.

Treatment of acute schizophrenia with molindone.

Abuzzahab FS.

J Clin Pharmacol. 1973 May-Jun;13(5):226-33. No abstract available.

PMID:
4575563
4.

Molindone--a new antipsychotic drug.

[No authors listed]

Med Lett Drugs Ther. 1975 Jul 4;17(14):59. No abstract available.

PMID:
237228
5.

A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient.

Binder R, Glick I, Rice M.

J Clin Psychiatry. 1981 May;42(5):203-6.

PMID:
7217025
6.

Clinical experience with molindone hydrochloride in geriatric patients.

Peper M.

J Clin Psychiatry. 1985 Aug;46(8 Pt 2):26-9.

PMID:
3894339
7.

Review of clinical and laboratory experiences with molindone hydrochloride.

Claghorn JL.

J Clin Psychiatry. 1985 Aug;46(8 Pt 2):30-3.

PMID:
3894340
8.

A pilot study of the short-term antianxiety effects of molindone HCl.

Kellner R, Gervais RH, Pathak D.

J Clin Pharmacol New Drugs. 1972 Nov-Dec;12(11):472-6. No abstract available.

PMID:
4563663
9.

Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.

Itil TM, Polvan N, Ucok A, Eper E, Güven F, Hsu W.

Behav Neuropsychiatry. 1971 Dec;3(9):6-13. No abstract available.

PMID:
4948869
10.

Weight reduction in schizophrenics by molindone.

Gardos G, Cole JO.

Am J Psychiatry. 1977 Mar;134(3):302-4.

PMID:
842709
11.

Molindone: a pilot evaluation during the premenstruum.

Shader RI, Harmatz JS.

Curr Ther Res Clin Exp. 1975 Apr;17(4):403-6. No abstract available.

PMID:
804388
12.

Clinical evaluation of a new psychotropic drug--molindone.

Ramsay RA, Lehmann HE, Ban TA, Saxena BM, Bennett J.

Int Z Klin Pharmakol Ther Toxikol. 1970 Jan;3(1):46-8. No abstract available.

PMID:
4909378
13.

Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics.

Escobar JI, Mann JJ, Keller J, Wilkins J, Mason B, Mills MJ.

J Clin Psychiatry. 1985 Aug;46(8 Pt 2):15-9.

PMID:
3894337
14.

Relation of serum molindone levels to serum prolactin levels and antipsychotic response.

Pandurangi AK, Narasimhachari N, Blackard WG, Landa BS.

J Clin Psychiatry. 1989 Oct;50(10):379-81.

PMID:
2676994
15.

Comparison of trifluoperazine and molindone in chronic schizophrenic patients.

Freeman H, Frederick AN.

Curr Ther Res Clin Exp. 1969 Nov;11(11):670-6. No abstract available.

PMID:
4982301
16.

Molindone in chronic schizophrenia.

Clark ML, Huber WK, Sakata K, Fowles DC, Serafetinides EA.

Clin Pharmacol Ther. 1970 Sep-Oct;11(5):680-8. No abstract available.

PMID:
4917090
17.

A clinical comparison of molindone hydrochloride with trifluoperazine in psychotic outpatients.

Brauzer B, Goldstein BJ.

Curr Ther Res Clin Exp. 1971 Mar;13(3):152-7. No abstract available.

PMID:
4998285
18.

Molindone hydrochloride treatment of hospitalized children with conduct disorder.

Greenhill LL, Solomon M, Pleak R, Ambrosini P.

J Clin Psychiatry. 1985 Aug;46(8 Pt 2):20-5.

PMID:
3894338
19.

Effect of molindone on weight change in hospitalized schizophrenic patients.

Parent MM, Roy S, Sramek J, Lawson W, Herrera J.

Drug Intell Clin Pharm. 1986 Nov;20(11):873-5.

PMID:
3780420
20.

Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.

Itil TM, Polvan N, Ucok A, Eper E, Güven F, Hsu W.

Behav Neuropsychiatry. 1971 Aug-Sep;3(5):25-32. No abstract available.

PMID:
4948596

Supplemental Content

Support Center